How to Buy Mei Pharma Stock
Mei Pharma Inc
MEI Pharma, Inc. , a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer.
Mei Pharma stock last closed at $3.06, up 0% from the previous day, and has decreased 49% in one year. It has underperformed other stocks in the Biotechnology industry by 0.31 percentage points. Mei Pharma stock is currently +1.66% from its 52-week low of $3.01, and -61.61% from its 52-week high of $7.97.
There are currently 6.66M shares of MEIP outstanding. The market cap of MEIP is $20.39M. In the past 24 hours, 11,077 MEIP shares were traded.
How to Buy Mei Pharma Stock
Wondering how to invest in Mei Pharma stock? Here's how.
- Decide where to buy Mei Pharma stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Mei Pharma stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your payment method and add your details.
- Evaluate Mei Pharma stock: The Mei Pharma ticker symbol is MEIP. Is Mei Pharma stock a good investment? Should you buy shares of MEIP? How do MEIP's underlying business fundamentals look? Do top analysts think Mei Pharma is a good buy? Why has MEIP's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if MEIP is a good stock to buy).
- Place your MEIP buy order: Decide if you will purchase MEIP shares at the current market price or use a limit order to purchase MEIP stock at a particular price.
- Track your MEIP investment: Create a watchlist to the latest updates on your position in Mei Pharma shares.
Step 1: Decide where to buy Mei Pharma stock
You will need an online brokerage account to access the NASDAQ market and buy MEIP stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to buy MEIP stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new trading account.
- Submit your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've finished signing up on one of the best stock trading apps, you need to deposit funds:
Watch the tutorial below if you need help transferring funds into your new brokerage account.
Step 4: Evaluate Mei Pharma stock
After you have identified the best place to buy Mei Pharma stock, it's important to analyze their stock before you invest, so you can comprehend the risk and opportunity.
Mei Pharma shares data
MEIP Overview
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on MEIP's stock page.
Is MEIP stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge MEIP's fair value.
Using relative valuations metrics:
- MEIP may be undervalued based on its P/E ratio of 1.03x, relative to Biotechnology industry P/E ratio of 7.63x
- MEIP could be undervalued based on its P/B ratio of 0.34x, relative to Biotechnology industry P/B ratio of 5.99x
You can do additional valuation analysis on MEIP's stock here.
MEIP Financial Overview
Positive Health Checks:
- MEIP profit margin has gone up from -49.8% to 27.3% in the past year.
- MEIP has cash burn of 53033000. It has sufficient cash and short-term investments to cover this for at least one year.
- MEIP has a low debt to equity ratio of 0.32.
- There are more short-term assets than long-term liabilities on the MEIP balance sheet.
- Total MEIP debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the MEIP balance sheet.
- MEIP has $59.48M in cash and short term investments. This is sufficient to cover its annual cash burn of $53.03M.
Is it a good time to buy Mei Pharma stock, according to analysts?
Out of 1 Equities analysts who give recommendations on MEIP, the consensus analyst rating on Mei Pharma is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Mei Pharma stock forecast page.
MEIP Technicals
MEIP Earnings
Last year, MEIP revenue was $72.65M. In the last five year, MEIP's revenue has increased by 83.24% per year. This was faster than the Biotechnology industry average of 29.57%.
Find out more about MEIP's earnings and revenue performance here.
What are MEIP executives and large shareholders up to?
In the past 12 months, executives and large shareholders at MEIP have bought more shares than they have sold.
Anson Funds Management LP, 10% Owner of MEIP, was the latest MEIP insider to buy. They bought $250,600.00 worth of MEIP stock on Oct 20, 2023.
Dig into more about who owns MEIP shares here.
Does MEIP provide a stable income stream?
Mei Pharma pays a dividend of 57.19%, compared to the Biotechnology industry's average dividend yield of 15.03%. If you owned $1,000 of MEIP stock, you would have been paid $571.90 in the past 12 months.
Find more info about Mei Pharma dividend yield and history here.
What do other traders have to say about MEIP?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your MEIP buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute the order.
If you need additional info about investing in stocks on eToro, click the how to video below:
Step 6: Track your MEIP investment
Now that you own some MEIP shares, you'll want to stay up-to-date on your shares.
Put MEIP on a watchlist to get alerted to the latest events about your MEIP stock.
MEIP Feed
How to Buy Stock in Mei Pharma
To reiterate, here are the 6 steps for buying Mei Pharma stock:
- Decide where to buy Mei Pharma stock
- Sign up for your brokerage account
- Fund your brokerage account
- Evaluate Mei Pharma stock
- Place your MEIP buy order
- Track your MEIP investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to watch your new investment in Mei Pharma, add MEIP to your watchlist below.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.